BioCentury
ARTICLE | Financial News

VaxGen raises $20 million

May 24, 2001 7:00 AM UTC

VXGN, a developer of HIV/AIDS vaccines, raised $20 million in a private placement of series A 6% cumulative convertible preferred stock. The preferred stock is convertible into common shares at $23.22...